Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_product
|
| gptkbp:administeredBy |
oral spray
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
MGC Pharma
|
| gptkbp:mainIngredient |
gptkb:artemisinin
vitamin C curcumin boswellia serrata |
| gptkbp:marketedAs |
gptkb:MGC_Pharmaceuticals
|
| gptkbp:regulates |
not FDA approved
|
| gptkbp:studiedIn |
COVID-19 patients
|
| gptkbp:usedFor |
gptkb:COVID-19
|
| gptkbp:bfsParent |
gptkb:MGC_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
ArtemiC
|